Title : Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes.

Pub. Date : 2008 Jul

PMID : 18793589






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes. Vildagliptin dipeptidyl peptidase 4 Homo sapiens
2 BACKGROUND: Vildagliptin is a selective inhibitor of dipeptidyl peptidase IV (DPP-4) that improves glycemic control and pancreatic b-cell function in patients with Type 2 diabetes. Vildagliptin dipeptidyl peptidase 4 Homo sapiens
3 BACKGROUND: Vildagliptin is a selective inhibitor of dipeptidyl peptidase IV (DPP-4) that improves glycemic control and pancreatic b-cell function in patients with Type 2 diabetes. Vildagliptin dipeptidyl peptidase 4 Homo sapiens